Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Spectrum Pharmaceuticals Inc

+ Add to Watchlist

NTR:GR

5.606 EUR 0.019 0.34%

As of 10:51:52 ET on 03/05/2015.

Snapshot for Spectrum Pharmaceuticals Inc (NTR)

Open: 5.666 Day's Range: 5.529 - 5.749 Volume: 0
Previous Close: 5.625 52wk Range: 4.552 - 6.994 1-Yr Rtn: -7.66%

Stock Chart for NTR

No chart data available.
  • NTR:GR 5.529
  • 1D
  • 1M
  • 1Y
5.625
Interactive NTR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NTR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.6870
Est. PEG Ratio -
Market Cap (M EUR) 368.65
Shares Outstanding (M) 65.76
30 Day Average Volume 843
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.1500
Dividend Ex-Date 12/18/2012
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NTR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NTR

Spectrum Pharmaceuticals Inc. is a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology. The Company's strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products.

Rajesh C ShrotriyaChairman/CEOJoseph TurgeonPresident/COO
Kurt A GustafsonExec VP/CFOLee F AllenSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for NTR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil